BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37794456)

  • 1. Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2023 Oct; 22(1):270. PubMed ID: 37794456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD.
    Orlandi PF; Xie D; Yang W; Cohen JB; Deo R; Ricardo AC; Schrauben S; Wang X; Hamm LL; He J; Sondheimer JH; Kallem K; Townsend R; Raj D; Parsa A; Anderson AH; Feldman HI; ;
    J Am Soc Nephrol; 2020 Dec; 31(12):2912-2923. PubMed ID: 33023926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Arosio M; Trevisan R; Vedovato M; Cignarelli M; Andreozzi F; Nicolucci A; Pugliese G;
    Diabetes Care; 2012 Jan; 35(1):143-9. PubMed ID: 22124714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study.
    Masrouri S; Alijanzadeh D; Amiri M; Azizi F; Hadaegh F
    Ann Med; 2023 Dec; 55(1):2216020. PubMed ID: 37272290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial.
    Isakova T; Craven TE; Scialla JJ; Nickolas TL; Schnall A; Barzilay J; Schwartz AV;
    Bone; 2015 Sep; 78():23-7. PubMed ID: 25937184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
    Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V;
    Diabetologia; 2019 Nov; 62(11):1988-1997. PubMed ID: 31302707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study.
    Mohebi R; Bozorgmanesh M; Sheikholeslami F; Azizi F; Hadaegh F
    J Clin Hypertens (Greenwich); 2013 May; 15(5):350-8. PubMed ID: 23614851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Cohen JB; Yang W; Li L; Zhang X; Zheng Z; Orlandi P; Bansal N; Deo R; Lash JP; Rahman M; He J; Shafi T; Chen J; Cohen DL; Matsushita K; Shlipak MG; Wolf M; Go AS; Feldman HI;
    Am J Kidney Dis; 2022 Jan; 79(1):36-44.e1. PubMed ID: 34052355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study.
    Ataklte F; Song RJ; Upadhyay A; Musa Yola I; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2021 Aug; 10(16):e020301. PubMed ID: 34387110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of eGFR slope with all-cause mortality, macrovascular and microvascular outcomes in people with type 2 diabetes and early-stage chronic kidney disease.
    Jin Q; Kuen Lam CL; Fai Wan EY
    Diabetes Res Clin Pract; 2023 Nov; 205():110924. PubMed ID: 37778664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.
    Gil-Terrón N; Cerain-Herrero MJ; Subirana I; Rodríguez-Latre LM; Cunillera-Puértolas O; Mestre-Ferrer J; Grau M; Dégano IR; Elosua R; Marrugat J; Ramos R; Baena-Díez JM; Salvador-González B
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):212-218. PubMed ID: 30709697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney function decline is associated with mortality events: over a decade of follow-up from Tehran Lipid and Glucose Study.
    Masrouri S; Tamehri Zadeh SS; Pishgahi M; Azizi F; Shapiro MD; Hadaegh F
    J Nephrol; 2024 Jan; 37(1):107-118. PubMed ID: 37665526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a correlation between an eGFR slope measured over a 5-year period and incident cardiovascular events in the following 5 years among a Flemish general practice population: a retrospective cohort study.
    Van Pottelbergh G; Mamouris P; Opdeweegh N; Vaes B; Goderis G; Van Den Akker M
    BMJ Open; 2018 Nov; 8(11):e023594. PubMed ID: 30420350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated glomerular filtration rate in a population with normal to mildly reduced renal function as predictor of cardiovascular disease.
    Yahalom G; Kivity S; Segev S; Sidi Y; Kurnik D
    Eur J Prev Cardiol; 2014 Aug; 21(8):941-8. PubMed ID: 23382541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.
    Heerspink HJL; Karasik A; Thuresson M; Melzer-Cohen C; Chodick G; Khunti K; Wilding JPH; Garcia Rodriguez LA; Cea-Soriano L; Kohsaka S; Nicolucci A; Lucisano G; Lin FJ; Wang CY; Wittbrodt E; Fenici P; Kosiborod M
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):27-35. PubMed ID: 31862149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.